Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Alphafetoprotein: an obituary.

Sherman M.

J Hepatol. 2001 Apr;34(4):603-5. No abstract available.

PMID:
11394662
2.

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Ho S, Cheng P, Yuen J, Chan A, Leung N, Yeo W, Leung T, Lau WY, Li AK, Johnson PJ.

Br J Cancer. 1996 Apr;73(8):985-8.

3.
4.

[alpha-1 fetoproteins in the diagnosis of hepatoma and teratogenic neoplasms].

Lehmann FG.

Med Lab (Stuttg). 1977 Apr;30(4):87-99. German. No abstract available.

PMID:
69254
5.

Hepatocellular carcinoma.

Neill P.

Cent Afr J Med. 1987 Mar;33(3):85-6. No abstract available.

PMID:
2448042
6.

Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.

Terada R, Yamamoto K, Sakaguchi K, Kiyotoshi S, Yagi T, Sadamori H, Tsuji T.

J Gastroenterol Hepatol. 2001 Nov;16(11):1310-1. No abstract available.

PMID:
11903755
7.

[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)].

Tang ZY, Yang BH.

Zhonghua Zhong Liu Za Zhi. 1981 Aug;3(3):205-9. Chinese. No abstract available.

PMID:
6175491
8.

[Assay of alpha-fetoprotein by monoclonal antibodies: progress in the diagnosis of hepatocellular carcinoma?].

Bergman JF, Labadie H, Beaugrand M.

Gastroenterol Clin Biol. 1985 Oct;9(10):742. French. No abstract available.

PMID:
2415422
9.

Alpha-fetoprotein and hepatocellular carcinoma.

Colli A, Fraquelli M, Conte D.

Am J Gastroenterol. 2006 Aug;101(8):1939; author reply 1940-1. No abstract available.

PMID:
16928257
10.

Hepatoma associated protein.

[No authors listed]

J Assoc Physicians India. 1979 Apr;27(4):340-3. No abstract available.

PMID:
93600
11.

Alpha-fetoprotein testing in Papua New Guinea.

Booth PB.

P N G Med J. 1977 Sep;20(3):144. No abstract available.

PMID:
79275
12.

Research on high risk groups of primary hepatocellular carcinoma (PHC).

Yu LY.

Prog Clin Biol Res. 1983;132E:475-82. No abstract available.

PMID:
6196791
13.

Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.

Li X, Wu K, Fan D.

Hepatology. 2009 Jul;50(1):325. doi: 10.1002/hep.23028. No abstract available. Corrected and republished in: Hepatology. 2009 Nov;50(5):1682.

PMID:
19492428
14.

[The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].

Liao HY.

Zhonghua Gan Zang Bing Za Zhi. 2005 May;13(5):379-80. Chinese. No abstract available.

PMID:
15918977
15.

Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.

Trapé J, Botargues JM, Porta F, Ricós C, Badal JM, Salinas R, Sala M, Roca A.

Clin Chem. 2003 Jul;49(7):1209-11. No abstract available.

16.

[AFP sero-survey and early diagnosis of liver cell cancer in the Qidong field (author's transl)].

Zhu YR.

Zhonghua Zhong Liu Za Zhi. 1981 Feb;3(1):35-8. Chinese. No abstract available.

PMID:
6171395
17.

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.

Riener MO, Stenner F, Liewen H, Hellerbrand C, Bahra M, Kristiansen G.

Hepatology. 2009 Jul;50(1):326. doi: 10.1002/hep.23053. No abstract available.

PMID:
19496179
18.

[Ultrasonic evaluation of small hepatocellular carcinoma: on the diagnostic problems and the limits of detectability].

Kurioka N, Kanno T, Kim K, Toda S, So K, Nakajima S, Oka H, Asai H, Kuroki T, Harihara S, et al.

Nihon Shokakibyo Gakkai Zasshi. 1985 Feb;82(2):247-54. Japanese. No abstract available.

PMID:
2582166
19.

Preventative care in chronic liver diseases.

O'Rorke JE, O'Keefe M.

J Gen Intern Med. 2000 Apr;15(4):273-4. No abstract available.

20.

[Subclinical hepatocellular carcinoma].

Tang ZY.

Zhonghua Zhong Liu Za Zhi. 1983 May;5(3):226-8. Chinese. No abstract available.

PMID:
6194949

Supplemental Content

Support Center